Related Experiment Video
Updated: Oct 15, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
What will we ask to artificial intelligence for cardiovascular medicine in the next decade?
Guglielmo Gallone1,2, Francesco Bruno3,4, Fabrizio D'Ascenzo3,4
1Division of Cardiology, Cardiovascular and Thoracic Department, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy - guglielmo.gallone@gmail.com.
Abstract:
Artificial intelligence (AI) comprises a wide range of technologies and methods with heterogeneous degrees of complexity, applications, and abilities. In the cardiovascular field, AI holds the potential to fulfil many unsolved challenges, eventually translating into improved patient care. In particular, AI appears as the most promising tool to overcome the gap between ever-increasing data-rich technologies and their practical implementation in cardiovascular research, in the cardiologist routine, in the patient daily life and at the healthcare-policy level. A multiplicity of AI technologies is progressively pervading several aspects of precision cardiovascular medicine including early diagnosis, automated imaging processing and interpretation, disease sub-phenotyping, risk prediction and remote monitoring systems. Several methodological, logistical, educational, and ethical challenges are emerging by integrating AI systems at any stage of cardiovascular medicine. This review will discuss the basics of AI methods, the growing body of evidence supporting the role of AI in the cardiovascular field and the challenges to overcome for an effective AI-integrated cardiovascular medicine.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cardiomyopathy V: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies

